Introduction {#s1}
============

Indirect flight muscles (IFMs) of flying insects display the highest known metabolic rates in the animal kingdom ([@bib60]). In *Drosophila*, two sets of IFMs, the dorsal-longitudinal muscles (DLMs) and the perpendicularly oriented dorso-ventral muscles (DVMs) are anchored to the thoracic cuticle and move the wings indirectly by deforming the thoracic exoskeleton rather than by acting directly on the wings. Each adult IFM is approximately 1 mm long and 100 µm wide ([@bib53]) and contains about 1000 nuclei ([@bib37]). To supply these large muscles with sufficient oxygen, an extensive network of gas-filled tracheal tubes not only superficially enwraps the IFMs, but also invades the myotube interior. This remarkable physiological adaptation minimizes the distance for oxygen diffusion from tracheoles to muscle mitochondria ([@bib60]; [@bib63]) and provides efficient gas exchange for aerobic respiration to sustain flight over long time periods ([@bib16]).

Tracheal cell migration is controlled by Fibroblast growth factor (FGF) signaling ([@bib13]; [@bib20]). The FGF ligand Branchless (Bnl) acts as a chemoattractant ([@bib54]) that promotes tracheal cell motility by activating the receptor tyrosine-kinase (RTK) Breathless (Btl) on tracheal cells ([@bib23]). IFMs receive their tracheal supply from tracheal cells that extend from the thoracic air sac primordium towards the notum region of the wing imaginal disc during larval development ([@bib43]). Subsequently, during metamorphosis, tracheal terminal branches (tracheoles) ramify on and invade the developing IFMs ([@bib35]). Tracheal invasion into IFMs depends on the attraction of tracheal branches by Bnl FGF secreted on the muscle surface, followed by a switch to release of FGF from the interior transverse (T)-tubule system ([@bib35]). The T-tubule system is a network of tubular longitudinal and transversal membranes that extend around each sarcomere and are required for excitation-contraction coupling ([@bib39]). It is continuous with the plasma membrane and was proposed to provide entry points for invasion of tracheal branches into the IFMs ([@bib35]). However, how tracheal cells interact with and enter the myotube, and how this process is coordinated with muscle development, has not been clear.

Tracheal invasion into IFMs presumably requires dynamic remodeling of extracellular matrix (ECM) and plasma membranes, but the underlying mechanisms are not well understood. Matrix metalloproteinases (MMPs) are involved in tissue reorganization during branching morphogenesis in various systems, including the mammalian lung ([@bib1]; [@bib64]), mammary gland ([@bib64]), and the *Drosophila* tracheal system ([@bib33]). The *Drosophila* genome encodes two MMPs, MMP1 and MMP2, which perform common and distinct functions during tissue remodeling ([@bib29]; [@bib34]). MMP1 was shown to be required for tracheal remodeling during larval growth ([@bib14] ) and MMP2 for normal outgrowth of the air sac primordium ([@bib58]). MMPs can be either secreted or membrane-tethered ([@bib25]; [@bib34] ), and are thought to function mainly as enzymes cleaving ECM components. However, MMP-mediated proteolysis can also modulate signaling by processing growth factors such as TNF $\alpha$ and TGF $\beta$ ([@bib10]; [@bib66]), by regulating growth factor availability and mobility ([@bib26]; [@bib58]), or by cleaving growth factor receptors ([@bib28]). MMP2 was shown to restrict FGF signaling through a lateral inhibition mechanism that maintains highest levels of FGF signaling in tracheal tip cells ([@bib58]). Moreover, MMPs can regulate mammary gland development independently of their proteolytic activity ([@bib22]; [@bib31]).

To understand the mechanisms underlying tracheal invasion into IFMs, we analyzed the dynamics of the process in vivo. This revealed that tracheal cells invade IFMs directionally and migrate inside the myotubes with dynamic growth-cone-like structures at branch tips until tracheal branches fill the myotube volume. MMP1 activity is required in tracheal cells for normal invasive behavior and for the dynamic organization of growth-cone-like branch tips. We found that MMP1 remodels the Collagen IV-containing ECM around invading branch tips, suggesting that tracheal-derived MMP1 sustains branch invasion by modulating the properties of the surrounding matrix. 

Results {#s2}
=======

Tracheae invade flight muscles in a non-stereotyped, but coordinated manner {#s2-1}
---------------------------------------------------------------------------

To understand the mode of IFM tracheation, we first analyzed tracheal branch pathways on the surface of and within IFMs. We focused our analysis on DLMs, which receive their tracheal supply from thoracic air sacs ([Figure 1A](#fig1){ref-type="fig"}). Stochastic multicolor labeling of tracheal cells ([@bib32]) revealed that multicellular air sacs converge into unicellular tubes ([Figure 1B](#fig1){ref-type="fig"}) with ramified tracheal terminal cells at their ends ([Figure 1B'](#fig1){ref-type="fig"}). Unlike tracheal terminal cells in other tissues, IFM tracheal cells not only ramify on the myotube surface, but also inside the syncytial myotube ([Figure 1C,C' and D,D'](#fig1){ref-type="fig"}; [Video 1](#video1){ref-type="video"}; [@bib35]). The cell bodies, including the nuclei, of IFM tracheal terminal cells reside on the myotube surface ([Figure 1C,C'' and D,D''](#fig1){ref-type="fig"}), while IFM nuclei are distributed throughout the muscle between myofibril bundles as well as near the muscle surface ([Figure 1C,C''' and D,D'''](#fig1){ref-type="fig"}).

![Tracheal terminal cell branches occupy separate territories in IFMs.\
(**A--A'**) Sagittal section of an adult thorax with dorsal longitudinal muscles (DLMs) stained for F-actin (magenta). Tracheal branches, visualized by their autofluorescence (green) arise from the thoracic air sacs adjacent to IFMs. (**B**) Stochastic multicolor labeling of tracheal cells in a sagittal section of an adult thorax. Multicellular tubes (**B'**) emanating from air sacs (AS) are superficial branches (SB) with tracheal terminal cells at their ends. Terminal cell branches spread on the muscle surface and invade as internal branches (IB) into the myotube. Note that individually labeled terminal cells occupy largely separate territories in IFMs (**B'**). (**C,D**) Tracheal branch supply of a single myotube in sagittal (**C--C'''**) and cross- (**D--D'''**) section stained for F-actin (magenta), LaminDm0 (cyan; all nuclei) and DSRF (yellow; tracheal terminal cell nuclei). Tracheal autofluorescence is shown in green. Cell bodies of tracheal terminal cells with DSRF-positive nuclei are located on the myotube surface. Terminal branches spread on the myotube surface, but also invade between and within myofibril bundles. (**E**) Single MARCM-labeled terminal tracheal cell in a developing IFM 75 hr APF. The tracheal cell, labeled with cytoplasmic GFP (green) and nuclear DSRF (yellow), extends fine tracheoles parallel to myofibrils (magenta). Color-coding of depth (**E'**) indicates that a single tracheal cell ramifies deep into the myotube. The color map to the upper right indicates depth in the z-axis. (**F,G**) Segmented IFM tracheal terminal cell color-coded for branch straightness (**F**) and branch orientation angle (**G**). Note that the majority of branches extend straight projections (**F**) and that branches extending from a given terminal cell often display a bias towards one orientation along the myotube long axis (**G**). (**H--H'**) Close-up of branches from two differentially labeled tracheal terminal cells (green and magenta). Note that while individual terminal cells occupy largely separate territories within the myotube, some branches of adjacent cells appear to be in close proximity or direct contact (arrowheads in **H'**). H' shows an orthogonal section in the x-z plane indicated by a dashed line in H. Scale bars: 100 μm (**A, A',B**), 50 μm (**B'**), 10 μm (**C--G**), 5 μm (**H,H'**).](elife-48857-fig1){#fig1}

###### Organization of tracheal branch invasion into a single IFM syncytium.

3D animation of z-stack of a single DLM stained for F-actin (magenta). Immunostaining against LaminDm0 (cyan) labels all nuclei, DSRF (yellow) labels tracheal terminal cell nuclei. Tracheal branches (green) were visualized by their autofluorescence.

10.7554/eLife.48857.004

In each IFM, branch invasion starts between myofibril bundles and fine subcellular tracheal branches (tracheoles) also invade myofibril bundles ([Figure 1D,D'](#fig1){ref-type="fig"}; [Video 1](#video1){ref-type="video"}), with most tracheoles extending parallel to the myofibrils ([Figure 1E,E'](#fig1){ref-type="fig"}). The number and morphology of terminal cells supplying a specific DLM was variable between individuals, indicating that the tracheal branching pattern in IFMs is not stereotyped ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Interestingly, however, the number of tracheal branches was relatively uniform along DLM myotubes ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, n = 6). These findings suggest that branches originating from tracheal terminal cells uniformly fill the available myotube volume in a manner that is non-stereotyped, but tightly coordinated with myotube morphology.

Tracheal cells occupy separate territories within the myotube {#s2-2}
-------------------------------------------------------------

To investigate how tracheal cells arrange within myotubes to fill their volume, we generated animals carrying individually marked tracheal cells. Morphometric analysis of 31 individual IFM terminal tracheal cells revealed that these cells display highly variable cellular architectures, as measured by cellular volume, sum of branch lengths, and the number of branch and terminal points ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). However, certain features were more uniform among cells. At least 95% of the branches of a given cell were aligned with the myotube axis ([Figure 1F](#fig1){ref-type="fig"}; n = 31) and the direction of branches was often biased towards one end of the myotube ([Figure 1G](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Stochastic multicolor labeling revealed that individual tracheal terminal cells occupy largely non-overlapping territories ([Figure 1B'](#fig1){ref-type="fig"}). Interestingly, at the borders of such territories, branches from different cells were occasionally in close proximity or in direct contact ([Figure 1H,H'](#fig1){ref-type="fig"}). These findings suggest that invading tracheal cells fill the available space within the myotube, but minimize overlaps, possibly mediated by contact-dependent repulsion between tracheal cells.

Innervation precedes tracheal invasion into IFM myotubes {#s2-3}
--------------------------------------------------------

To investigate the dynamics of IFM tracheation, we analyzed a time course between 32 hr APF and adulthood. While DVMs form de novo by fusion of adult muscle progenitors (AMPs), DLMs form by fusion of AMPs to larval 'template' muscles 8 hr APF ([@bib61]; [@bib8]; [@bib12]). Tracheal invasion into DLMs begins around 48 hr APF when tracheoles start to enwrap and invade the myotubes ([Figure 2A,A'](#fig2){ref-type="fig"}; [@bib35]). Around 60 hr APF DLM tracheation is not complete yet, indicating that tracheal ramification inside DLM myotubes continues during late pupal development ([Figure 2B,B'](#fig2){ref-type="fig"}). Interestingly, prior to entry of tracheal branches into myotubes, motor neurons have already innervated IFMs ([Figure 2A,A''](#fig2){ref-type="fig"}). Furthermore, the distribution of tracheal branches was largely distinct from that of motor neurons ([Figure 2B,B''](#fig2){ref-type="fig"}) and the main tracheal branches did not overlap with motor neuron axons, suggesting that tracheae and neurons use separate entry routes into the muscle. Thus, tracheal invasion into myotubes is a comparatively slow process that occurs after IFM innervation.

![IFM innervation precedes tracheal invasion.\
(**A,B**) DLMs at 48 hr APF (**A**) and 61 hr APF (**B**). Tracheal cell membranes are labeled by palmitoylated mNeonGreen (green) driven by *btl*-Gal4. F-actin is labeled with Phalloidin (blue) and neurons with HRP (magenta). Note that at 48 hr APF (**A--A''**), when tracheal invasion has just started, the muscle is already innervated with motor neurons. At 61 hr APF tracheae have invaded the myotube (**B--B''**). Cross-sections to the right show that most tracheal branches reside on the surface of the myotube at 48 hr APF, whereas tracheal branches are inside the myotube at 61 hr APF. Scale bars: 10 μm (**A,B**).](elife-48857-fig2){#fig2}

IFM mitochondria enwrap tracheal branches, but not vice versa {#s2-4}
-------------------------------------------------------------

Classical studies using dye infiltration experiments ([@bib63]) described that IFM tracheole endings encircle IFM mitochondria, suggesting that mitochondria may be involved in guiding tracheal invasion inside the muscle. To investigate how mitochondria might influence tracheal branch pathways we analyzed the interrelationship of mitochondria and tracheae during IFM development using transmission electron microscopy (TEM). During sarcomere assembly in DLMs mitochondria change from a tubular morphology with few cristae to globular mitochondria with an elaborate cristae network ([Figure 2---figure supplement 1A--H](#fig2s1){ref-type="fig"}), accompanied by a dramatic increase in mitochondrial size between 48 hr APF and eclosion ([Figure 2---figure supplement 1I](#fig2s1){ref-type="fig"}). Adult IFMs are packed with globular mitochondria between myofibrils, yielding tracheal branches closely associated with mitochondria along their entire length. However, in contrast to earlier reports ([@bib63]), we were unable to detect any cases in which tracheal branches encircled mitochondria. Strikingly, however, we found that some mitochondria partially enwrapped tracheal branches ([Figure 2---figure supplement 1J--K](#fig2s1){ref-type="fig"}; [Video 2](#video2){ref-type="video"}). These mitochondria showed no differences in volume or sphericity compared to mitochondria that were located farther away from tracheal branches ([Figure 2---figure supplement 1L,M](#fig2s1){ref-type="fig"}). Taken together, tracheal branches interact closely with mitochondria due to their dense packing between myofibrils and the partial enwrapping of tracheoles by mitochondria.

###### Mitochondria can enwrap IFM tracheoles.

3D animation of an IFM tracheal branch surrounded by multiple mitochondria. Mitochondria were labeled by immunostaining against ATP5A (magenta). The tracheal branch (green) was visualized by its autofluorescence.

10.7554/eLife.48857.008

*salm*-dependent flight muscle fate is required for tracheal invasion {#s2-5}
---------------------------------------------------------------------

We used tissue-specific RNAi to systematically search for tracheal- and muscle-derived factors, respectively, required for IFM invasion ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). As previously reported ([@bib35]), the Bnl FGF chemoattractant is essential for IFM tracheation, as muscle-specific knock-down of Bnl completely abolished tracheal invasion into IFMs ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}). Interestingly, the trachealess muscles developed into adult IFMs with normal morphology of myofibrils, sarcomeres, and mitochondria, and with innervation by motor neurons ([Figure 3---figure supplement 1B,C,E--H](#fig3s1){ref-type="fig"}), suggesting that tracheal supply is dispensable for normal IFM development. However, adult flies lacking IFM tracheae were unable to fly. This finding prompted us to search for additional genes with roles in IFM tracheation using muscle-specific RNAi. We analyzed a set of 66 genes ([Supplementary file 2](#supp2){ref-type="supplementary-material"}), which are required in IFMs for muscle function (flight), but not for normal muscle morphology ([@bib47]), suggesting that these genes may be involved in IFM tracheation. We used *mef2*-Gal4 to knock down each of these genes in all muscles, and screened for changes in IFM tracheation. However, among the genes tested only the transcription factor Spalt major (Salm), which specifies fibrillar muscle fate ([@bib48]), was required for tracheal invasion into muscles ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Thus, as tracheal invasion only occurs in fibrillar muscles and not in other muscle types in *Drosophila* ([@bib35]), Salm-dependent processes appear to play a key role in preparing myotubes for tracheal invasion.

MMP1 is required in tracheal cells for invasion into myotubes {#s2-6}
-------------------------------------------------------------

We used an analogous RNAi approach to search for factors required in tracheal cells for branch invasion into myotubes ([Supplementary file 2](#supp2){ref-type="supplementary-material"}) and identified an important role of matrix metalloproteinase 1 (MMP1) in this process. Knock-down of *Mmp1* in tracheal cells using *btl*-Gal4 led to altered tracheal branching on IFMs ([Figure 3A--C'](#fig3){ref-type="fig"}). The angles between branches emanating from tracheal cell bodies on the myotube surface were reduced compared to control animals ([Figure 3E--G](#fig3){ref-type="fig"}). In addition, fewer tracheal branches were found inside myotubes ([Figure 3H,I,J](#fig3){ref-type="fig"}) and the fraction of myotube volume occupied by tracheoles was reduced (L). Furthermore, the tracheoles inside the myotubes showed fewer branch points compared to controls ([Figure 3M](#fig3){ref-type="fig"}). Consistent with these findings, tracheal *Mmp1* knock-down led to reduced flight ability, indicating compromised muscle function of adult flies ([Figure 3N](#fig3){ref-type="fig"}). We confirmed the specificity of the RNAi effect using two independent dsRNAs targeting different regions of the *Mmp1* gene, *Mmp1* RNAi 1 (JF01336, TRIP; [Figure 3B,B',J,J'](#fig3){ref-type="fig"}) and *Mmp1* RNAi 2 ([@bib56]), which led to comparable tracheal phenotypes ([Figure 3L,M](#fig3){ref-type="fig"}). Furthermore, introducing the *Mmp1* homologue of *Drosophila pseudoobscura* under the control of its endogenous promoter ([@bib9]) into animals expressing *Mmp1* dsRNA in tracheal cells restored normal tracheal IFM invasion ([Figure 3C,C',J,J',L,M](#fig3){ref-type="fig"}). Together these results indicate that MMP1 is required in tracheal cells for invasion into myotubes and that the defects observed upon expression of *Mmp1* dsRNA are due to depletion of *Mmp1* ([Figure 3A--C](#fig3){ref-type="fig"}).

![Tracheal branch invasion requires MMP1 function in tracheal cells.\
(**A--D'**) Sagittal sections of adult thoraxes stained for F-actin (magenta). Autofluorescence of tracheae is shown in green. (**E,F**) show close-ups of tracheal branches on the IFM surface. Orthogonal sections (yz) are shown to the right. Note altered spreading of tracheal branches on the myotube surface upon tracheal-specific *Mmp1* knock-down. The effect of *Mmp1* knock-down was rescued by the *Drosophila pseudoobscura Mmp1* homologue *GA18484* (Dpse *Mmp1*; **C**). Tracheal expression of TIMP (**D**) phenocopies the effect of RNAi-mediated *Mmp1* depletion. (**G**) The angles between branches emerging from tracheal cell bodies on the myotube surface are reduced in tracheal *Mmp1* knock-down animals compared to controls. (**H--K**) Sagittal sections of single myotubes. Note reduced number of tracheoles inside myotubes upon tracheal *Mmp1* knock-down (**I**) compared to control (**H**). The effect of *Mmp1* knock-down was rescued by the *Drosophila pseudoobscura Mmp1* homologue *GA18484* (Dpse *Mmp1*; **J**). Tracheal expression of TIMP (**K**) led to reduced tracheal invasion. (**L,M**) In a defined muscle volume the fraction occupied by tracheal branches (**L**) and the number of branch points per tracheal branch inside the myotube (**M**) were determined. At least 20 myotubes were scored. (**N**) Flight ability was measured as the percentage of flies that landed at the bottom immediately after throwing them into a Plexiglas cylinder (n = 4 experiments). Note that tracheal *Mmp1* knock-down leads to reduced flight ability due to impaired muscle function. *Mmp1* was depleted using *Mmp1* RNAi (1) or *Mmp1* RNAi (2) ([@bib56]). \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001; NS not significant. Scale bars: 100 μm (**A--D'**), 20 μm (**E,F**) and 5 μm (**H--K'**).\
10.7554/eLife.48857.012Figure 3---source data 1.Source data for [Figure 3L,M,N](#fig3){ref-type="fig"}.](elife-48857-fig3){#fig3}

To assess the distribution of MMP1 in IFM tracheae we analyzed flies carrying a genomic fosmid clone in which [MMP1](http://flybase.org/search/Mmp1) has been fused at its C-terminus to superfolder GFP and FLAG, TY1, and V5 epitope tags (fTRG145; [@bib42]). MMP1^fTRG145^ signals were detectable by anti-GFP immunostaining on the IFM-associated tracheal air sac epithelium and along tracheal branches inside IFM myotubes ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), consistent with our finding that MMP1 is required for normal invasive behavior of tracheal branches in IFM myotubes.

Since Mmp1 has membrane-tethered and secreted isoforms ([@bib25]), Mmp1 could exhibit both cell-autonomous and cell-non-autonomous functions during branch invasion. To investigate Mmp1´s mode of action, we generated mosaic animals carrying clones of cells homozygous for the amorphic alleles *Mmp1^Q112^* and *Mmp1^2^* ([@bib33]). However, we were not able to detect *Mmp1^Q112^* or *Mmp1^2^* mutant cells among IFM tracheae of mosaic animals (75 hr APF). Although we cannot exclude the presence of additional cell-lethal mutations on the *Mmp1* mutant chromosomes, the absence of homozygous *Mmp1* mutant clones from IFMs is consistent with an essential cell-autonomous requirement of MMP1 in IFM tracheation. Taken together, these findings indicate that MMP1 is required in tracheal cells for normal invasion into IFMs.

Tracheal invasion depends on MMP1 proteolytic activity {#s2-7}
------------------------------------------------------

To test whether MMP1 catalytic activity, rather than a non-catalytic function (e.g. of the MMP1 hemopexin domains), was required for branch invasion, we expressed the *Drosophila* tissue inhibitor of metalloproteinases (TIMP; [@bib36]) in tracheal cells under the control of *btl*-Gal4. TIMPs inhibit MMP activity by occupying the active site of the protease ([@bib15]), and *Drosophila* TIMP was shown to inhibit MMP1 and MMP2 ([@bib33]; [@bib59]). *btl*-Gal4-driven expression of TIMP resulted in air sac defects ([Figure 3D,D'](#fig3){ref-type="fig"}), but adult flies were viable. The number of tracheal branches invading IFMs, as well as the number of tracheal branch points inside myotubes were reduced in these animals ([Figure 3K,K',L,M](#fig3){ref-type="fig"}), resembling the effect of tracheal *Mmp1* knock-down, although the defects caused by tracheal TIMP expression were milder compared to *Mmp1* knock-down. Together, these findings indicate that MMP catalytic activity is required in tracheal cells for normal IFM invasion.

MMP1 modulates the speed of tracheal invasion into IFMs {#s2-8}
-------------------------------------------------------

To investigate the dynamics of IFM tracheal invasion and the function of MMP1 in this process, we developed a long-term live imaging protocol for visualizing IFM tracheation in living pupae ([Figure 4A](#fig4){ref-type="fig"}). Tracheal cell membranes were labeled with *btl*-Gal4-driven palmitoylated mKate2 (palm-mKate2) and muscles were labeled with Myofilin-GFP. We imaged the onset of IFM tracheal invasion at 48 hr APF, when tracheal branches extending from the air sac primordia begin to invade IFM myotubes ([Figure 4A,A'](#fig4){ref-type="fig"}). Tracheal branches extending from the medioscutal air sac invaded the myotube in a directional fashion from posterior to anterior along the myotube long axis ([Figure 4B,B'](#fig4){ref-type="fig"}; [Video 3](#video3){ref-type="video"} upper panel). Such directional invasion of tracheae was also apparent for tracheal branches that extend from the lateroscutal air sac and invade dorso-ventral IFMs ([Video 4](#video4){ref-type="video"} upper panel). Tracheal invasion upon tracheal-specific knock-down of *Mmp1* was still directional ([Video 4](#video4){ref-type="video"} lower panel), but the extent of tracheal ramification inside the myotubes at 62 hr APF was reduced compared to wild-type controls ([Figure 4](#fig4){ref-type="fig"}, compare B,B' to C,C'; [Video 3](#video3){ref-type="video"}). In control pupae the number of tracheal branches in a defined myotube volume close to the medioscutal air sac initially increased in a linear fashion and ceased at approximately 56 hr APF ([Figure 4D](#fig4){ref-type="fig"}; n = 5). In contrast, *Mmp1*-depleted tracheal cells entered at constant, but lower speed into the myotube ([Figure 4D](#fig4){ref-type="fig"}; n = 8). Thus, tracheal MMP1 function is required for the normal dynamics and speed of IFM tracheation ([Figure 4D'](#fig4){ref-type="fig"}).

![Normal dynamics of tracheal IFM invasion depends on tracheal Mmp1 function.\
(**A--A'**) Schematics of pupal flight muscles and air sacs 48 hr APF. The pupal case around the head and thorax was removed for live imaging of tracheal invasion into IFMs. Tracheal invasion into dorsal longitudinal muscles (DLMs) from the medioscutal (**m**) air sacs was imaged from a dorsal view (**A'**). Tracheal invasion into dorso-ventral muscles (DVMs) from the lateroscutal (**l**) air sacs was imaged from a lateral view (**A'**). (**B,C**) Stills of tracheal invasion into DLMs by branches arising from the medioscutal air sac in a control pupa (**B,B'**) and a tracheal *Mmp1* knock-down pupa (**C,C'**). Palmitoylated mKate2 (palm-mKate2, green in B,C) labels tracheal cells, Myofilin-GFP (magenta in B,C) labels myotubes. B' and C' show palm-mKate2 intensities displayed as a heat map. The first time point (00:00 hr) corresponds to 48 hr APF. (**D**) Quantification of tracheal branches over time in a defined myotube volume close to the medioscutal air sac. The speed of invasion (increase in tracheal branch fraction per minute; **D'**) was calculated for control and *Mmp1* knock-down pupae (n = 3). (**E,F**) Stills of tracheal branch tips invading DVMs in control (**E**) and in tracheal *Mmp1* knock-down pupa (**F**). Note that growth-cone like structures (arrowheads) are confined to branch tips in the wild type, but are found also along branch stalks upon *Mmp1* knock-down (n = 3). Scale bars: 20 μm (**B,C**) and 10 μm (**E,F**).\
10.7554/eLife.48857.015Figure 4---source data 1.Source data for [Figure 4D](#fig4){ref-type="fig"}.](elife-48857-fig4){#fig4}

###### Dorsal view of tracheal invasion into DLMs in control and tracheal-specific *Mmp1* knock-down animals.

Time-lapse movies of tracheal invasion into DLMs in pupae 48 h APF. Tracheal cells are labeled by palmitoylated mKate2, IFMs are labeled by Myofilin-GFP. Dorsal views of a wild-type control pupa (top) and a tracheal *Mmp1* knock-down pupa (bottom) are shown. The movies were acquired with a 40x objective and a frame rate of 10 min in resonant scanning mode (Leica SP8) over 14 h. Z-stacks of \~100 μm (0.35 μm step size) were acquired.

10.7554/eLife.48857.016

###### Lateral view of tracheal invasion into DVMs in control and tracheal-specific *Mmp1* knock-down animals.

Time-lapse movies of tracheal invasion into DVMs in pupae 48 h APF. Tracheal cells are labeled by palmitoylated mKate2, IFMs are labeled by Myofilin-GFP. Lateral views of a wild-type control pupa (top) and a tracheal *Mmp1* knock-down pupa (bottom) are shown. The movies were acquired with a 40x objective and a frame rate of 10 min in resonant scanning mode (Leica SP8) over 14 h. Z-stacks of \~100 μm (0.35 μm step size) were acquired.

10.7554/eLife.48857.017

Invading tracheae display growth cone-like structures at branch tips {#s2-9}
--------------------------------------------------------------------

The altered dynamics of branch invasion upon tracheal *Mmp1* knock-down suggests that MMP1 proteolysis could be required for clearance of the entry path for tracheae into the myotube or for modulating signaling molecules that promote branch invasion. To elucidate the role of MMP1 we investigated the behavior of individual tracheal branch tips in wild-type and in tracheal MMP1 knock-down animals. Invading branches displayed growth cone-like structures at their tips, with dynamic protrusions resembling lamellipodia and filopodia ([Figure 4E](#fig4){ref-type="fig"}; [Video 5](#video5){ref-type="video"}). Growth-cone like structures at branch tips were also observed upon tracheal *Mmp1* knock-down ([Figure 4F](#fig4){ref-type="fig"}; [Video 5](#video5){ref-type="video"}), and the presence of filopodia on these structures suggests that FGF signaling is active to promote migration also in cells with reduced MMP1 levels ([@bib40]). However, the growth-cone like structures in the MMP1-depleted cells did not remain confined to the branch tips as invasion proceeded ([Figure 4](#fig4){ref-type="fig"}, compare E to F). Instead, multiple enlarged protrusions resembling lamellipodia persisted, often behind the branch tip, suggesting that trachea-derived MMP1 is required for the dynamic organization of growth cone-like structures during tracheal migration inside the myotube.

###### Close-up of invading tracheal branch tips in control and tracheal-specific *Mmp1* knock-down animals.

Close-up movies of tracheal invasion into DVMs in pupae 53 h APF. Tracheal cells are labeled by palmitoylated mKate2. A wild-type control (left) and a tracheal *Mmp1* knock-down pupa (right) are shown. Arrowheads point at growth cone-like structures. The movies were acquired with a 40x objective and a frame rate of 10 min in resonant scanning mode (Leica SP8). Z-stacks of \~100 μm (0.35 μm step size) were acquired.

10.7554/eLife.48857.018

Extracellular matrix components are distributed non-uniformly along invading tracheal branches {#s2-10}
----------------------------------------------------------------------------------------------

The reduced speed of tracheal branch invasion upon *Mmp1* knock-down could arise from a defect in the ability of tracheal cells to clear their path through the surrounding BM, the removal or remodeling of which may require MMP1 function. To investigate potential roles of MMP1 in BM remodeling during branch invasion, we first analyzed the distribution of the BM components Laminin and Perlecan around tracheal branches at the onset of tracheal invasion 48 hr APF. Compared to adult IFM tracheae, which were covered with Laminin- and Perlecan-containing BM ([Figure 5---figure supplement 1C--C''](#fig5s1){ref-type="fig"}), invading tracheal branches at 48 hr APF showed little detectable BM ([Figure 5---figure supplement 1A--B'](#fig5s1){ref-type="fig"}). The muscle surface, however, was covered with Laminin and Perlecan ([Figure 5---figure supplement 1A--B'](#fig5s1){ref-type="fig"}). Of note, these ECM components also lined membrane invaginations on the myotube surface ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), presumably representing openings of the T-tubule network ([@bib35]). Entry of tracheal branches into these invaginations could require MMP activity. However, tracheal *Mmp1* knock-down did not notably affect the levels and distribution of Perlecan around branch tips, and *Mmp1*-depleted tracheal cells invaded the myotube via the membrane invaginations ([Figure 5---figure supplement 1E--F'](#fig5s1){ref-type="fig"}).

Next, we analyzed the composition of the BM around tracheal branches in adult IFMs ([Figure 5](#fig5){ref-type="fig"}; [Video 6](#video6){ref-type="video"}). In controls Laminin was detected along the entire length of tracheal branches, both on the muscle surface and inside myotubes ([Figure 5A,A'',B,B''](#fig5){ref-type="fig"}; [Video 6](#video6){ref-type="video"}). In contrast, Perlecan and Collagen IV covered the tracheal stalks between myofibril bundles, but were not detectable around the tracheal tip regions inside myofibril bundles ([Figure 5A,A',B,B'](#fig5){ref-type="fig"}; [Video 6](#video6){ref-type="video"}), indicating that the BM around invading branch tips has a distinct composition and may be thinner than the BM surrounding the branch stalks.

![Tracheal stalk and tip regions show distinct basement membrane compositions.\
(**A,B**) Distribution of the ECM components Perlecan (**A,A'**), CollagenIV-GFP (**B,B'**) and Laminin or LamininB1-GFP (**A,A'',B,B''**) around tracheal branches inside an adult IFM myotube. Note that Laminin extends along the entire length of tracheal branches, whereas Perlecan and Collagen IV are excluded from branch tips inside myofibril bundles. Bottom panels show close-up view of the regions marked by dashed boxes. (**C--F**) Distribution of Perlecan (**C--D'**) and CollagenIV-GFP (**E--F'**) around tracheal branches in wild-type control (**C,C',E,E'**) and *Mmp1* tracheal knock-down (**D,D',F,F'**) adult myotubes. Note that Perlecan distribution is not affected by *Mmp1* knock-down, whereas CollagenIV-GFP extends into the tip region of some branches in *Mmp1* knock-down, but not in control animals (**F,F'** arrowheads). *Mmp1* was depleted using *Mmp1* RNAi (1). Scale bars: 7 μm (**A--B'''**), 5 μm (**C--F'**).](elife-48857-fig5){#fig5}

###### Distribution of ECM around single adult DLM with tracheae.

3D animation of ECM around a single adult DLM with tracheae. ECM components Laminin (magenta) and Perlecan (cyan) were visualized by immunostaining. Tracheal branches (green) were visualized by their autofluorescence. Note that tracheae enter the myotube through ECM-lined invaginations of the muscle surface.

10.7554/eLife.48857.021

MMP1 is involved in remodeling of collagen IV around tracheal branches inside IFM myotubes {#s2-11}
------------------------------------------------------------------------------------------

We asked whether tracheal-derived MMP1 influences the distribution of BM membrane components associated with tracheal branches. Depletion of tracheal MMP1 did not appear to affect the levels and distribution of trachea-associated Perlecan ([Figure 5C--D'](#fig5){ref-type="fig"}). However, *Mmp1* knock-down had a distinct effect on the distribution of Collagen IV. Whereas tracheal branch tips inside myotubes were devoid of Collagen IV in wild-type controls, 13% (n = 59) of *Mmp1*-depleted tracheal branch tips showed Collagen IV signals around the tip region ([Figure 5E--F'](#fig5){ref-type="fig"}). These findings suggest that trachea-derived MMP1 promotes invasion of tracheal branches through clearance of Collagen IV during migration inside the myotube.

Discussion {#s3}
==========

Perfusion of tissues by oxygen-transporting vessels is a key prerequisite for all body functions in animals. In flying insects the extreme energy demands of flight are met by a network of tracheal tubes that minimize the distance for oxygen diffusion to mitochondria by extending branches into the interior of the flight muscles. This requires a new developmental process that enables tracheal cells to invade and spread throughout the IFM myotubes, unlike all other insect muscle types, where tracheoles ramify on the muscle surface only. Hence, flight muscle tracheation provides a powerful model to study the interactions that promote invasion of sprouting branches into tissues.

To investigate the cellular and molecular mechanisms underlying tracheal invasion into IFMs, we analyzed the dynamics of the process in vivo. First, through live imaging of muscle tracheation, we found that tracheal cells invade the muscle directionally with growth cone-like structures at branch tips. Tracheoles ramify inside the muscle until they uniformly fill the myotube volume. Intriguingly, however, single-cell analyses revealed that individual IFM tracheal cells occupy largely separate territories within the myotube, reminiscent of neuronal dendritic tiling ([@bib18]), suggesting that IFM tracheation involves repulsion between tracheal cells. Second, using a tissue-specific RNAi-based approach to identify factors required for branch invasion, we found that MMP1 activity is required in tracheal cells for normal speed of invasion and for the dynamic organization of growth-cone-like structures at migrating branch tips. Third, we showed that ECM components are distributed non-uniformly along IFM tracheal branches, with Laminin covering the entire length of tracheal branches, whereas Perlecan and Collagen IV are excluded from the tracheal tip regions inside the myotube. Fourth, we showed that MMP1 is involved in remodeling the Collagen IV-containing matrix around invading branch tips. Together, these findings suggest that MMP1 sustains tracheal branch invasion by modulating the dynamic behavior of tracheal branch tips and by remodeling the surrounding ECM.

A unique aspect of IFM tracheation is the fact that tracheal terminal cells enter and ramify within another cell, in this case a syncytial muscle. Although this system represents a specialized adaptation towards the extensive oxygen demand of this tissue, the underlying cellular mechanisms may be relevant also for the development of other organs, such as the vasculature. Tracheal invasion involves dynamic adhesion to the substrate, guidance of tracheal cells, and remodeling of the myotube ECM and plasma membrane to accommodate the invading tubes. Angiogenesis, which is based on tip-cell-guided migration with invasive protrusions probing the environment, involves similar challenges, for instance in the case of blood vessels that grow into collagen-packed cornea tissue or into bones ([@bib50]).

The ability of tracheal cells to enter the IFM myotubes is likely to depend on permissive and instructive cues provided by the muscle, as well as on factors that act in the tracheal cells to mediate their invasive behavior. We showed that tracheal invasion into IFMs critically depends on the transcription factor Salm, which specifies the fibrillar muscle type ([@bib48]). The *salm*-dependent cell fate switch appears to induce a program that renders the myotube permissive for tracheal invasion, for example through modulating properties of the muscle plasma membrane or ECM. In addition, Salm may regulate factors that mediate the dynamic redistribution of the Bnl FGF chemoattractant from the muscle surface to the internal T-tubule network in IFMs. This switch in the mode of the subcellular pathway of FGF secretion was shown to guide tracheal cells into IFMs ([@bib35]).

Classical electron microscopy studies suggested that tracheoles enter the IFMs through plasma membrane invaginations that are continuous with T-tubules, and then spread through the T-tubule network ([@bib51]; [@bib52]; [@bib63]). Other muscle types that lack these membrane invaginations are not invaded by tracheal branches ([@bib35]). Surprisingly, however, we did not find evidence that a normally organized T-tubule system is required for tracheal ingrowth and spreading in *Drosophila* IFMs, since *amphiphysin (amph)* mutants with a disorganized T-tubule system ([@bib39]) showed a normal distribution of tracheoles in IFMs ([Figure 5---figure supplement 1G,H](#fig5s1){ref-type="fig"}). Although the exact topology of the T-tubule system in wild-type and in *amph* mutant IFMs remain to be characterized, these results suggest that invasion into and spreading of tracheal cells inside IFMs may not depend on a pre-existing regular membrane invagination system.

IFM tracheoles are closely associated with mitochondria, thus minimizing the distance for gas exchange via diffusion. While we confirmed this close association by electron and high-resolution confocal microscopy, we found, contrary to an earlier report ([@bib63]), no evidence that IFM tracheole endings encircle mitochondria. These earlier observations were based on dye infiltration experiments, which may be prone to artifacts due to leakage of the injected dye used for tracheal staining. Conversely, we discovered mitochondria that were partially enwrapping IFM tracheoles. This is likely due to extensive fusion of mitochondria, resulting in giant sleeve-like mitochondrial geometries around tracheal tubes in IFMs. Intriguingly, this arrangement is reminiscent of the mitochondria that wrap around the axoneme in sperm tails ([@bib65]). Thus, mitochondrial wrapping may represent a common mechanism to sustain the extensive energy demands of specialized motile cell types such as flight muscle or sperm.

MMP1 modulates invasive behavior of IFM tracheal cells {#s3-1}
------------------------------------------------------

In addition to the muscle-derived factors discussed above, we show that the matrix metalloproteinase MMP1 is required in IFM tracheal cells for their normal invasive behavior. ECM remodeling is crucial for branching morphogenesis of various organs, and MMPs are the main enzymes that mediate ECM degradation ([@bib4]). We showed that while the BM around invading branches is very thin at the beginning of IFM tracheation at 48 hr APF, tracheal branches in adult IFMs are surrounded by abundant, but molecularly heterogeneous, BM along their length. Laminin, but not Perlecan and Collagen IV, is present around branch tips. The presence of this molecularly distinct BM at the invasive branch tips suggests a reduced stiffness and increased distensibility of the BM, which has been observed also in other invading epithelia, including the mammalian salivary gland ([@bib2]; [@bib17]; [@bib19]), mammary gland ([@bib11]) and lung ([@bib30]). We found that depletion of MMP1 from tracheal cells led to a distinct effect on ECM remodeling. The tips of MMP1-depleted tracheal cells in mature IFMs displayed residual Collagen IV, suggesting that MMP1 is involved in modulating the mechanical properties of the ECM surrounding invading tracheal branch tips by removing CollagenIV-containing ECM. The moderate strength of this effect in MMP1 knock-down animals may be attributable to incomplete RNAi-mediated depletion or genetic redundancy of MMP1 with other matrix-degrading proteases. Furthermore, we cannot rule out that MMP1 might act on other ECM components, besides Collagen IV, that we did not test.

Since MMP1 has membrane-tethered and secreted isoforms ([@bib25]), MMP1 may execute both cell-autonomous and cell-non-autonomous functions. However, our results based on genetic mosaic analysis suggest that MMP1 acts in a cell-autonomous manner during IFM invasion. This function relies largely on MMP proteolytic activity, as we showed by expressing the MMP activity inhibitor TIMP. These findings raise the question as to which are the relevant substrates of MMP1 activity.

Historically, MMPs have been mainly associated with ECM remodeling ([@bib4]). However, MMPs have broad substrate specificity and can cleave, besides several ECM components, also non-ECM proteins. Directional migration of tracheal cells in the embryo is mediated by the graded distribution of the Bnl FGF chemoattractant, which is expressed locally in small clusters of cells ([@bib54]). In case of the developing IFMs, the redirection of FGF secretion from the cell surface to T-tubules explains the switch from superficial to invasive tracheal cell migration ([@bib35]). Yet, it is not clear whether and how an FGF chemotactic gradient could be established along a syncytial muscle to control directional persistence of tracheal cell migration along the IFMs. Since MMP1 is expressed in the air sac primordium ([@bib58]), tracheal cell-associated MMP1 might influence the spatial distribution of the FGF chemoattractant by degrading Bnl FGF and thereby generating a local sink of chemoattractant around the invading branches. Localized degradation of the FGF chemoattractant by the migrating branch tips could sustain motility of sprouting branches towards areas with higher concentrations of FGF, even if FGF is initially distributed uniformly on the muscle surface. Although we have not been able to visualize the distribution of endogenous Bnl FGF on pupal IFMs due to the limited sensitivity of the available tools, analogous chemotactic gradients generated by migrating cells have been described in different developmental processes ([@bib7]; [@bib55]; [@bib57]). A regulatory interplay between MMPs and FGFs has been reported to operate also in other contexts of branching morphogenesis. MMP2-expressing tracheal tip cells are part of a lateral inhibition mechanism during larval *Drosophila* air sac development ([@bib58]). Here, cells at the tip of the air sac primordium receive highest levels of FGF signaling and induce ERK-dependent expression of genes, including *Mmp2* ([@bib58]). MMP2 mediates release of an inhibitory signal that acts non-autonomously to prevent FGF signaling in neighboring cells and consequently restricts tip cell fate to the MMP2-expressing cells. The nature of the inhibitory signal is still unknown. Interestingly, expression of MMP2 can be induced by FGF2 in mammalian endothelial cells ([@bib24]). Mammalian MMP2 can also cleave FGFR1 to release a soluble receptor ectodomain fragment, which retains the ability to bind FGF and may influence FGF availability in the vascular BM ([@bib28]). Together with our results, these findings suggest that MMP proteolytic activity may play conserved roles in different developmental contexts by controlling the invasive behavior of migrating cells through remodeling the properties of the surrounding matrix as well as by regulating growth factor signaling.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                 Designation                                       Source or\                                                        Identifiers                        Additional\
  (species)\                                                                                      reference                                                                                            information
  or resource                                                                                                                                                                                          
  --------------------------------------------- ------------------------------------------------- ----------------------------------------------------------------- ---------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Genetic reagent (*Drosophila melanogaster*)   *mef2-Gal4*                                       [@bib38]\                                                                                            
                                                                                                  Dev Biol, 171(1), 169--181                                                                           

  Genetic reagent (*Drosophila melanogaster*)   *btl-Gal4*                                        [@bib49] Development, Growth and Differentation, 38(1), 99--106                                      

  Genetic reagent (*Drosophila melanogaster*)   *UAS-palmKate2-K7*                                [@bib6] *Nat Cell Biol* 18: 727--739                                                                 

  Genetic reagent (*Drosophila melanogaster*)   *UAS-palm-mNeonGreen*                             [@bib44]*Development* 144: 657--663                                                                  

  Genetic reagent (*Drosophila melanogaster*)   *UAS-FRT~FRT\>STOP\>FRT~-myr::smGFP-HA_V5_FLAG*   [@bib32] *PNAS* 112: E2967--76                                                                       

  Genetic reagent (*Drosophila melanogaster*)   *y^1^ v^1^;; UAS-Mmp1_RNAi\_*(*1*)                Bloomington Stock Center                                          BDSC: 31489                        

  Genetic reagent (*Drosophila melanogaster*)   *UAS-Mmp1_RNAi\_*(*2*)                            [@bib56] *EMBO J* 25(22): 5294--5304                                                                 

  Genetic reagent (*Drosophila melanogaster*)   *;; FlyFos066598\_*\                              this study                                                                                           *Mmp1* ortholog GA18484 from*Drosophila pseudoobscura* in genomic FlyFos vector inserted into VK13 attPlanding site (76A2).See "Drosophila strains and genetics "in theMaterials andmethods section.
                                                *DpseMmp1_GA18484 (attP-9A/VK13)*                                                                                                                      

  Genetic reagent (*Drosophila melanogaster*)   *FRTG13 mmp1^Q273^/CyO, Dfd-GMR-YFP*              this study                                                                                           See "Genetic labeling\
                                                                                                                                                                                                       of tracheal cell clones"in the Materials and methods section

  Genetic reagent (*Drosophila melanogaster*)   *FRTG13 mmp1^Q112^/CyO, Dfd-GMR-YFP*              this study                                                                                           See "Genetic labelingof tracheal cell clones "in the Materialsand methods section

  Genetic reagent (*Drosophila melanogaster*)   *FRTG13 mmp1^2^/CyO, Dfd-GMR-YFP*                 this study                                                                                           See "Genetic labeling of tracheal cell clones "in the Materialsand methods section

  Genetic reagent (*Drosophila melanogaster*)   *LanB1-GFP*                                       Vienna Drosophila Resource Center; [@bib42]                       VDRC: fTRG681                      

  Genetic reagent (*Drosophila melanogaster*)   *Mmp1-GFP*                                        Vienna Drosophila Resource Center; [@bib42]                       VDRC: fTRG145                      

  Genetic reagent (*Drosophila melanogaster*)   *Myofilin-GFP*                                    Vienna Drosophila Resource Center; [@bib42]                       VDRC: fTRG501                      

  Genetic reagent (*Drosophila melanogaster*)   *Vkg-GFP*                                         [@bib5] *Genetics* 175: 1505--1531                                                                   

  Genetic reagent (*Drosophila melanogaster*)   *UAS-TIMP*                                        Bloomington Stock Center                                          BDSC: 58708                        

  Genetic reagent (*Drosophila melanogaster*)   *amph^26^*                                        Bloomington Stock Center                                          BDSC: 6498                         

  Antibody                                      Rabbit polyclonal anti-Bnl                        [@bib21] Cell, 99(2): 211--220                                                                       1:250

  Antibody                                      Mouse monoclonal anti-Mmp1                        Developmental Studies Hybridoma Bank                              Mix of mouse monoclonal\           1:10/1:100/1:100
                                                                                                                                                                    antibodies 3B8D12, 3A6B4, 5H7B11   

  Antibody                                      Mouse monoclonal anti-Dlg1                        Developmental Studies Hybridoma Bank                              4F3                                1:200

  Antibody                                      Mouse monoclonal anti-DSRF                        [@bib41] Development 122(5): 1395--1407                           mAb 2--161                         1:100

  Antibody                                      Mouse monoclonal anti-ATP5A                       Abcam                                                             ab14748                            1:100

  Antibody                                      Chicken polyclonal anti-GFP                       Abcam                                                             ab13970                            1:500

  Antibody                                      Chicken polyclonal anti-HA                        Abcam                                                             ab9111                             1:200

  Antibody                                      Mouse monoclonal anti-FLAG (M2)                   Sigma                                                             M2; Sigma-F1804                    1:1000

  Antibody                                      Guinea pig polyclonal anti-LaminDm0               gift from Georg Krohne, University of Würzburg                                                       1:1000

  Antibody                                      Rabbit polyclonal anti-Laminin                    [@bib46] Development 133(19):3805--3815                                                              1:1500

  Chemical compound, drug                       Phalloidin-TRITC                                  Sigma                                                                                                1:1000

  Recombinant DNA reagent                       fosmid clone FlyFos066598                         [@bib9] Nat Methods 6 (6): 435--437                               FlyFos066598                       fosmid clone FlyFos066598 containing the *Drosophila pseudoobscura Mmp1* homologue GA18484
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Drosophila* strains and genetics {#s4-1}
---------------------------------

The following *Drosophila* stocks are described in FlyBase and were obtained from the Bloomington stock center, unless noted otherwise: *btl*-Gal4 ([@bib49]), *mef2*-Gal4 ([@bib38]), UAS-*palm-mKate2* ([@bib6]), UAS-*palm-mNeonGreen* ([@bib44]), UAS-*FRT\>STOP\>FRT-myr::smGFP-HA_V5_FLAG* ([@bib32]), UAS-*Mmp1* RNAi ([@bib56]), *Mmp1^Q273^, Mmp1^Q112^, Mmp1^2^* ([@bib14]), *amph^26^* ([@bib39]), Mmp1-GFP (fTRG145), Myofilin-GFP (fTRG501), LamininB1-GFP (fTRG681; [@bib42]), Vkg-GFP (G205; [@bib5]). Additional UAS-RNAi stocks were obtained from the TRiP or VDRC collections ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Crosses for RNAi knock-down were performed at 27°C. Heterozygous animals carrying the Gal4 driver (*mef2*-Gal4 or *btl*-Gal4 crossed to *y w* flies) were used as controls in RNAi experiments. For rescue experiments, the fosmid clone FlyFos066598 ([@bib9]) containing the *Drosophila pseudoobscura Mmp1* homologue *GA18484* was integrated into the attP-9A/VK13 (76A2) landing site using PhiC31 integrase ([@bib3]).

Genetic labeling of tracheal cell clones {#s4-2}
----------------------------------------

For multicolor labeling of tracheal cells *btl-Gal4* flies were crossed to *hsFlp::Pest;; UAS-FRT\>STOP\>FRT-myr::smGFP-HA_V5_FLAG* ([@bib32]). L3 larvae were heat-shocked for 20 min at 37°C. The MARCM system ([@bib27]) was used for clonal labeling of tracheal cells. For wild-type MARCM clones *y w hs-Flp122; FRT40A tub-GAL80; btl-GAL4 UAS-GFP* females were crossed to *y w hs-Flp122; FRT40A FRTG13; btl-GAL4 UAS-GFP* males. For *Mmp1* mutant clones *y w hs-Flp122; FRTG13 tub-GAL80; btl-GAL4 UAS-GFP* females were crossed to males carrying *Mmp1^2^*, *Mmp1^Q112^* or *Mmp1^Q273^* mutations recombined on FRTG13 chromosomes. L3 larvae were heat-shocked for 2 hr at 37°C. Pupae were staged by collecting white pre-pupae and dissected 75 hr after puparium formation (APF) at 27°C.

Flight test {#s4-3}
-----------

Adult flies (one to five days after eclosion) were kept for four days at 30°C before testing for flight ability in a Plexiglas cylinder as described in [@bib62]. We determined the percentage of flies that landed at the bottom immediately after throwing them into the Plexiglas cylinder.

Immunostainings {#s4-4}
---------------

For immunostainings of developing IFMs, white pre-pupae were staged at 27°C and dissected at the desired time APF. Pupae up to 60 hr APF were dissected according to the protocol for developing IFMs ([@bib62]). Older pupae and adults (1--6 days after eclosion) were dissected according to the protocol for adult IFMs ([@bib62]).

Primary antibodies were chicken anti-GFP (1:500; Abcam ab13970), mouse anti-DSRF (1:100; [@bib41]), chicken anti-HA (1:200; Abcam ab9111), anti-FLAG(M2) (1:1000; Sigma F1804), mouse anti-Dlg1 (1:200; DSHB 4F3), guinea-pig anti-LaminDm0 (1:1000; gift from Georg Krohne, University of Würzburg), rabbit anti-Laminin (1:1500; [@bib46]), mouse anti-MMP1 (mix of mouse monoclonal antibodies 3B8D12, 3A6B4, 5H7B11, 1:10/1:100/1:100; DSHB; [@bib33]), rabbit anti-Perlecan (1:2000; [@bib46]), anti-ATP5A (1:100; Abcam ab14748). Goat secondary antibodies were conjugated with Alexa Fluor 488 or Dylight 488 (1:500; Life Technologies), Alexa Fluor 555, Alexa Fluor 568 (1:500; Life Technologies), Dylight 550 (1:500; Thermo Fisher) or Alexa Fluor 647 (1:500; Life Technologies). Tracheae in adult IFMs were visualized by their autofluorescence upon UV (405 nm) excitation. Phalloidin-TRITC (1:1000; Sigma) was used to stain F-actin and anti-HRP-Alexa Fluor 647 (1:100; Dianova) to label neurons.

Transmission electron microscopy {#s4-5}
--------------------------------

Pupal and adult IFM samples were fixed at room temperature (RT) in 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer (PB) for at least 2 hr and were then transferred to 4°C overnight. On the next day, samples were fixed with 2% OsO~4~ in 0.1 M PB for 1 hr on ice in the dark. Next, samples were washed five times using ddH~2~O and stained *en bloc* with 2% uranyl acetate (UA) for 30 min at RT in the dark. After five washes in ddH~2~O, samples were dehydrated in an ethanol series (50%, 70%, 80%, 90%, 95%), each for 3 min on ice and twice in 100% ethanol for 5 min at RT. Following dehydration, samples were incubated twice in pure propylene oxide (PO) for 15 min and then transferred to an epon-PO mixture (1:1) to allow resin penetration over night. After removal of PO by slow evaporation over 24 hr, samples were embedded in freshly prepared epon (polymerization at 60°C for 24 hr). 90 nm sections were prepared on a Leica UC7 microtome and stained with 2% UA for 30 min and 0.4% lead citrate for 3 min to enhance contrast. Images were acquired with a Zeiss EM900 (80 kV) using a side-mounted camera (Osis).

Light microscopy and image analysis {#s4-6}
-----------------------------------

Stained specimens were imaged on a Zeiss LSM880 Airyscan confocal microscope or a Zeiss LSM710 confocal microscope. Z-projections were generated with Imaris (v9, Bitplane) using the '3D view' or with Fiji (GPL v2; [@bib45]). Where indicated, images were acquired with the Airyscan detector and subjected to Airyscan processing.

Live imaging of tracheal invasion into pupal IFMs {#s4-7}
-------------------------------------------------

Live imaging of IFM tracheation was performed on a Leica SP8 confocal microscope using a 40x/1.3 NA oil immersion objective, resonant scanning mode and Hybrid Detectors. Pupae expressing *btl*-Gal4-driven palmitoylated mKate2 (palm-mKate2; [@bib6]) to label tracheal cells and Myofilin-GFP (fTRG501; [@bib42]) to label muscles were prepared for live imaging 48 hr APF after staging at 27°C. The pupal case around the head and thorax was removed using forceps. Pupae were fixed on a coverslip with heptane glue and covered with a gas-permeable membrane (bioFOLIE 25, In Vitro System and Services, Göttingen, Germany) using a spacer of 0.5 mm. The dorsal-most DLMs were imaged from a dorsal view. DVMs were imaged from a lateral view. Time-lapse movies were recorded with z-stacks (100 μm thickness, 0.35 μm step size) acquired every 10 min over 14 hr.

Analysis of tracheal invasion speed {#s4-8}
-----------------------------------

To quantify the progress of IFM tracheation over time movies were processed with Fiji. A binary movie sequence of tracheal invasion was generated by first creating a maximum intensity projection, followed by histogram normalization (1% saturation) and auto thresholding (Huang filter). In a ROI of approximately 1680 µm^2^ close to the medioscutal air sacs, changes in tracheal area fraction starting from 52 hr APF were assessed over time with the Time Series Analyzer Plugin.

Quantification of tracheal density in IFMs {#s4-9}
------------------------------------------

Confocal sections of tracheae in IFMs were taken below the muscle surface. Stacks of 9 μm thickness (step size 0.3 μm) were acquired along the selected myotube in different individuals. Tracheal branches were visualized in a myotube volume of approximately 3 × 10^4^ µm^3^. After average intensity projection, background subtraction (sliding paraboloid, radius 15), median filtering (radius 2), histogram normalization (1% saturation) and manual thresholding were performed in Fiji to generate binary images of tracheal branches. These binary images were used to determine the fraction of myotube area occupied by tracheal branches.

Quantification of tracheal branch points per myotube volume {#s4-10}
-----------------------------------------------------------

To determine the number of tracheal branch points in a myotube volume of approximately 3 × 10^4^ µm^3^ the same image raw data as described above were used. 3D binary images of tracheal branches were generated in Fiji by background subtraction (sliding paraboloid, radius 15), median filtering (radius 2), histogram normalization (1% saturation), Gaussian blur (sigma 0.2) and manual thresholding. The 3D binary images were subjected to the Skeletonize 3D plugin of Fiji to count the number of branches and branch points.

Analysis of tracheal branching angles {#s4-11}
-------------------------------------

The angles of branches extending from tracheal cell bodies on the IFM surface were determined by superimposing a circle with defined radius over a tracheal branch tree such that the circle covers the branch tree and the stalk. The intersections of tracheal branches with the circumference of the circle were recorded and plotted.

Morphometry of tracheal cells {#s4-12}
-----------------------------

Z-stacks of single MARCM-labeled tracheal cells were acquired with a step size of 0.5 μm. Brightness correction along z was applied during image acquisition to visualize finest branches deep inside the myotube. 3D binary images of tracheal branches were generated in Fiji by background subtraction (sliding paraboloid, radius 15), median filtering (radius 2) and manual thresholding, and were segmented in Imaris. The Surface tool of Imaris was used to determine the cellular volume. The Filament tracer tool was used to segment branches and to extract the sum of branch length, total number of branch points and terminal points, branch straightness, branch orientation angle and branching angle. Automated filament tracing was adjusted manually for correctness.

Analysis of mitochondrial morphology {#s4-13}
------------------------------------

Airyscan images of IFM mitochondria were acquired with a step size of 0.3 μm. Mitochondria were segmented using the Surface tool of Imaris with 'split touching objects' enabled. Analysis of segmented mitochondria was performed using the Vantage tool of Imaris.

Statistics and reproducibility {#s4-14}
------------------------------

For phenotypic analyses, sample size (n) was not predetermined using statistical methods, but was assessed by taking into account the variability of a given phenotype, determined by the standard deviation. Experiments were considered independent if the specimens analyzed were derived from different parental crosses. During experiments investigators were not blinded to allocation. For statistical analysis, the Kolmogorov-Smirnov test was applied, which does not require assumptions on the type of data distribution.

Quantification of mitochondria and tracheae in TEM sections {#s4-15}
-----------------------------------------------------------

For each developmental time point, at least three to five TEM cross-sections were analyzed for the area of mitochondria and tracheal lumen, respectively, by manually tracing the outlines of mitochondria and of tracheal lumen in ImageJ. The mean areas of mitochondria and of tracheal lumen, respectively, are shown in [Figure 2---figure supplement 1I](#fig2s1){ref-type="fig"}.
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###### Quantitative analysis of IFM tracheal terminal cell morphology.

Volume, sum of branch length, and total number of branch points and terminal points were extracted from 31 individually marked (MARCM clones) segmented terminal tracheal cells in wild-type pupae (75 hr APF).
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###### RNAi screen to identify genes required for IFM tracheal invasion.

Columns include gene identifiers and gene names of selected candidate genes, details about the RNAi lines used to knock down candidate genes, and the results of the screen for genes required for flight ability and tracheal invasion into myotubes.

10.7554/eLife.48857.024

###### Statistics Reporting Table.

10.7554/eLife.48857.025

Data availability {#s7}
=================

All data generated or analysed during this study are included in the manuscript and supporting files.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Mmp1 modulates invasive behavior of tracheal branches during ingression into *Drosophila* flight muscles\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by K VijayRaghavan as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Christos Samkovlis (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The study by Sauerwald and colleagues describes the mechanism of how tracheae invade and colonize *Drosophila* Salm-specified, fibrillar flight muscles during pupal development. Combining genetics with high-end imaging of live and fixed samples, and rigorous image analyses the authors provide a detailed description of the invasion process which requires directional migration of trachea inside the myotubes and spreading of the tracheal branches until they fill the myotubes. The authors characterize the dynamic behavior of the growth-cone-like structures at branch tips and the differential composition of the basal membrane along the tracheal branches. They show that Laminin is deposited along the entire tracheal branch while Perlecan and Collagen IV are restricted to the tracheal stalks. They provide causal genetic evidence for the role of MMP1 in the invasion process and implicate MMP1 in the dynamics of growth-cone-like branch tips through the remodeling of the ECM component Collagen IV. Based on the cell culture experiments, the authors propose an additional role for trachea-derived MMP1 in generating a chemoattractant gradient of FGF/Bnl around the migrating tracheal branches. The study provides novel insights into the mechanisms of muscle tracheation, which involves the paradigm of controlled cell invasion and intercellular crosstalk between different tracheal cells and the invaded myotube. The manuscript is well written and understandable, authors present a set of well-conducted, suited, high-quality experiments followed by rigorous data analyses and visualization generating a solid foundation to support the major conclusions of the study.

Essential revisions:

1\) Although they detected the proximity of the trachea to the muscle mitochondria they could not detect the spectacular wrapping of tracheal projections around these organelles. In this context, it would be interesting for the reader to provide a quantification of the EM analysis.

2\) To investigate the genetic determinants of the muscle-tracheal interactions, the authors performed small scale screen of preselected RNAi strains inactivating genes either in flight muscles or in the trachea. They show that the transcription factor Salm is required in the flight muscle for the attraction and penetration of tracheal cells. Conversely, Bnl signalling and Mmp1 are required in the tracheal cells for proper muscle invasion. They focused on the genetic analysis of Mmp1 in the process and they convincingly showed that Mmp activity is required for ECM remodelling. Interestingly collagen was the major target of Mmp1, compared to other ECM components like perlecan or laminin. The genetic analysis of Mmp1 inactivation suggested that additional roles for Mmp1 apart from the degradation of collagen. The authors tried to investigate the possibility that Bnl could be a proteolytic substrate of Mmp1. They overexpressed combinations of Bnl, Btl, and Mmp1 in S2 cells and detected Bnl and Mmp1 in the cellular extracts (or in culture medium?). They show a Western blot where they detect reduced Bnl when Mmp1 is coexpressed and conclude that Mmp1 cleaves and degrades Bnl. This experiment is poorly controlled and not necessary in the context of this work. If the authors want to argue that for specific cleavage of Bnl by Mmp1 they should also show in parallel the levels of Btl and another secreted protein like Delta or Notch in the same experiment.

3\) The study refers too many times to \"data not shown\". The data that are relevant should be presented and \"data not shown\" be avoided\"

4\) Did authors try to assess the MMP1 levels along the branches? Could the differential distribution of MMP1 support their proposed role for MMP1 in generating the Bnl gradient?

5\) Is MMP1-induced Bnl degradation in the cell culture system associated with reduced downstream signaling?

6\) The authors might comment on the frequency of mmp1LOF clones in time points earlier than 75h APF, otherwise, the last paragraph of the subsection "MMP1 is required in tracheal cells for invasion into myotubes",, remains very speculative.

7\) Concerning the Bnl/Btl signaling, they could look at ERK activation as potential evidence for target perturbation.

10.7554/eLife.48857.029

Author response

> Essential revisions:
>
> 1\) Although they detected the proximity of the trachea to the muscle mitochondria they could not detect the spectacular wrapping of tracheal projections around these organelles. In this context, it would be interesting for the reader to provide a quantification of the EM analysis.

We appreciate the reviewer´s comment. We carefully revisited our set of TEM data. In no case did we observe wrapping of tracheoles around mitochondria. To our knowledge, such wrapping has previously been reported only in studies based on dye infiltration experiments, which are prone to artifacts. However, in adult IFMs we found many cases of tracheoles that appeared to be partially enwrapped by large sleeve-like mitochondria. This is likely to be explained by the dramatic increase in mitochondrial size during late-pupal IFM development, which is accompanied by extensive fusion of mitochondria, giving rise to giant sleeve-like mitochondria around tracheal tubes. To support this point, we revisited our TEM images of IFM cross-sections at 32h h APF, 48 h APF and in adults, and analyzed the size of mitochondria and tracheal lumina. The cross-sectional area of mitochondria increased with developmental time, most dramatically between 48 h APF and adulthood, lending support to our hypothesis that growth and/or fusion of mitochondria results in enwrapping of tracheoles. We show the quantification of the EM data in a new panel (I) added to the figure supplement to Figure 2 (Figure 2---figure supplement 1I).

> 2\) To investigate the genetic determinants of the muscle-tracheal interactions, the authors performed small scale screen of preselected RNAi strains inactivating genes either in flight muscles or in the trachea. They show that the transcription factor Salm is required in the flight muscle for the attraction and penetration of tracheal cells. Conversely, Bnl signalling and mmp1 are required in the tracheal cells for proper muscle invasion. They focused on the genetic analysis of Mmp1 in the process and they convincingly showed that Mmp activity is required for ECM remodelling. Interestingly collagen was the major target of Mmp1, compared to other ECM components like perlecan or laminin. The genetic analysis of mmp1 inactivation suggested that additional roles for mmp1 apart from the degradation of collagen. The authors tried to investigate the possibility that Bnl could be a proteolytic substrate of Mmp1. They overexpressed combinations of Bnl, Btl, and Mmp1 in S2 cells and detected Bnl and Mmp1 in the cellular extracts (or in culture medium?). They show a Western blot where they detect reduced Bnl when mmp1 is coexpressed and conclude that Mmp1 cleaves and degrades Bnl. This experiment is poorly controlled and not necessary in the context of this work. If the authors want to argue that for specific cleavage of Bnl by Mmp1 they should also show in parallel the levels of Btl and another secreted protein like Delta or Notch in the same experiment.

We appreciate the reviewer´s comment regarding the cell culture experiments. We detected Bnl and Mmp1 proteins from cellular extracts as well as from the culture medium, indicating that both proteins were secreted by the cells. However, the experiment in Figure 6 shows an immunoblot of cellular extracts only. To address the specificity of Mmp1 activity towards Bnl as a possible proteolytic substrate, we tried to detect as an additional potential substrate the FGF receptor Breathless (Btl), but we were unable to obtain specific signals using an available rabbit anti-Btl antiserum.

To validate the results from the tissue culture experiments in vivo, we made extensive efforts to visualize the endogenous Bnl protein in IFMs. However, using the available reagents (anti-Bnl antiserum, flies expressing GFP-tagged Bnl from the endogenous *bnl* locus), we were unable to detect the Bnl protein in whole-mount preparations of pupal or adult flies. Given these results, we agree with the reviewer´s statement that the cell culture experiments do not contribute to the main conclusions of the paper. We therefore decided to remove the section describing these results, along with Figure 6, from the manuscript.

> 3\) The study refers too many times to \"data not shown\". The data that are relevant should be presented and \"data not shown\" be avoided\".

In the revised manuscript we present relevant data that was previously referred to as "data not shown":

Subsection "IFM mitochondria enwrap tracheal cells, but not vice versa": We added two panels to Figure 2---figure supplement 1L, M to show the quantitative analysis of mitochondria previously referred to as "data not shown".

Subsection "salm-dependent flight muscle fate is required for tracheal invasion": We now show the innervation of trachealess muscles of flies with muscle-specific knockdown of *bnl* previously referred to as "data not shown" (new panels E and F in Figure 3---figure supplement 1).

Discussion, fifth paragraph: The distribution of tracheoles in IFMs of *amph* mutants is shown in Figure 5---figure supplement 1G, H. We removed the reference to the number of tracheoles in *amph* mutants and the statement "data not shown".

> 4\) Did authors try to assess the MMP1 levels along the branches? Could the differential distribution of MMP1 support their proposed role for MMP1 in generating the Bnl gradient?

We tried hard to assess the distribution of Mmp1 protein using three different anti-Mmp1 monoclonal antibodies (3B8, 3A6, 5H7; Page-McCaw et al., 2003). However, although we tested various different fixation protocols (paraformaldehyde, glutaraldehyde, Bouin´s fixative), we were not able to obtain specific signals with these antibodies in immunostainings of whole-mount preparations of pupal or adult IFMs.

We also made considerable efforts to generate an endogenously tagged version of Mmp1. We inserted a V5 epitope tag into the MMP1 hinge region by targeting the endogenous *mmp1* locus using CRISPR-mediated genome editing. However, while V5-tagged Mmp1 protein was detectable in protein extracts by immunoblot, no specific signal was visible in anti-V5 immunostainings of whole-mount preparations of pupal or adult IFMs. We therefore did not include these results in the manuscript.

Moreover, we also analyzed flies carrying a genomic fosmid clone in which MMP1 has been fused at its C-terminus to superfolder GFP and FLAG, TY1, and V5 epitope tags (fTRG145; Sarov et al., 2016; VDRC). Although we were unable to detect MMP1-GFP signals in living specimens, we detected specific signals in whole-mount preparations stained with an anti-GFP antibody. Discrete MMP1-GFP staining was visible on the IFM-associated tracheal air sac epithelium and along tracheal branches inside IFM myotubes, consistent with our finding that MMP1 is required for normal invasive behavior of tracheal branches inside IFM myotubes. We describe these findings in the text (subsection "MMP1 is required in tracheal cells for invasion into myotubes") and show the data in a new supplementary figure (Figure 4---figure supplement 1).

Addressing the reviewer's question regarding the role of MMP1 in generating a Bnl gradient in IFMs, we tried extensively to detect Bnl FGF in situ, either in fixed specimens using anti-Bnl antibodies or in living pupal or adult specimens expressing a GFP-tagged knock-in allele of *bnl* (Du L, Sohr A, Yan G and Roy S (2018) Feedback regulation of cytoneme-mediated transport shapes a tissue-specific FGF morphogen gradient. *eLife* 7). However, neither of these approaches revealed specific signals in pupal or adult IFMs. Thus, based on these results we cannot provide more direct evidence for a role of MMP1 in modifying the distribution of Bnl FGF in developing IFMs.

> 5\) Is MMP1-induced Bnl degradation in the cell culture system associated with reduced downstream signaling?

To test whether signaling downstream of Bnl is reduced upon MMP1-induced degradation of Bnl we analyzed MAPK activation by detecting dpERK on immunoblots ([Author response image 1](#respfig1){ref-type="fig"}). This did not reveal clear changes in dpERK levels between cells transfected with MMP1 and control cells ([Author response image 1](#respfig1){ref-type="fig"}; compare lanes 3 and 4). Given these results, we agree with the reviewer´s statement that the cell culture experiments do not contribute to the main conclusions of the paper. We therefore decided to remove the section describing these results, along with Figure 6, from the manuscript.

![Immunoblot of cellular protein extracts of S2 cells transfected as indicated on top.](elife-48857-resp-fig1){#respfig1}

> 6\) The authors might comment on the frequency of mmp1LOF clones in time points earlier than 75h APF, otherwise, the last paragraph of the subsection "MMP1 is required in tracheal cells for invasion into myotubes", remains very speculative.

We have no data on the occurrence of *mmp1*^LOF^ mutant clones at stages earlier than 75h APF. We are aware that the conclusion is based on negative evidence and hence has to remain speculative. To take this into account we changed "*suggests*" to "*is consistent with*" in the conclusion of the paragraph, which now reads:

"Although we cannot exclude the presence of additional cell-lethal mutations on the Mmp1 mutant chromosomes, the absence of homozygous Mmp1 mutant clones from IFMs is consistent with an essential cell-autonomous requirement of MMP1 in IFM tracheation.".

> 7\) Concerning the Bnl/Btl signaling, they could look at ERK activation as potential evidence for target perturbation.

Please see above under 5.

[^1]: Wine Research Centre, The University of British Columbia, Vancouver, Canada.
